5CLM | Hydrolase | date | Jul 16, 2015 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | 1,4-Oxazine Bace1 Inhibitors | ||||||||||||||
authors | F.Rombouts, G.Tresadern, O.Delgado, C.Martinez Lamenca, M.Van Go A.Garcia-Molina, S.Alonso De Diego, D.Oehlrich, H.Prokopcova, J.M.Alonso, N.Austin, H.Borghys, S.Van Brandt, M.Surkyn, M.De Cl A.Vos, R.Alexander, G.Macdonald, D.Moechars, A.Trabanco, H.Gijse | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Beta-Secretase 1 Chain: A Fragment: Protease, Unp Residues 46-446 Synonym: Aspartyl Protease 2,Asp 2,Beta-Site Amyloid Precur Protein Cleaving Enzyme 1,Beta-Site App Cleaving Enzyme 1,M Membrane-Associated Aspartic Protease 2; Ec: 3.4.23.46 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Bace1, Bace, Kiaa1149 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: P 61 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.61 Å | ||||||||||||
ligand | 52K, CL, IOD | enzyme | Hydrolase E.C.3.4.23.46 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | 1,4-Oxazine beta-secretase (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads., Rombouts FJ, Tresadern G, Delgado O, Martinez Lamenca C, Van Gool M, Garcia-Molina A, Alonso De Diego SA, Oehlrich D, Prokopcova H, Alonso JM, Austin N, Borghys H, Van Brandt S, Surkyn M, De Cleyn M, Vos A, Alexander R, Macdonald GJ, Moechars D, Gijsen HJ, Trabanco AA, J Med Chem. 2015 Sep 17. PMID:26378740 |
Data retrieval |
View 5CLM in 3D |
Visual 3D analysis of 5CLM |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5CLM |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |